Answers are grounded in this paper and cite their sources.
To be able to advise future travelers about preventive measures, travel health professionals must be aware about the various travel‐related health risks. Usually there may be no real‐time data; it remains the responsibility for anyone in the field to use the most recent evidence available. Far too often, one observes, eg, in scientific presentations, that old data are used as a reference. Since 1984, we have repeatedly published a logarithmic scale of such risks 1 but for 20 years have not detailed the sources used for this figure. In the initial versions, many results originated from a single prospective, meanwhile obsolete, study,2 but already then, data from previous retrospective surveys on cholera and typhoid were included. Subsequently, the data set was expanded by adding poliomyelitis,3 hepatitis B,4 meningococcal disease,5 dengue,6 HIV infections,7 influenza,8,Legionella infections,9 Japanese encephalitis,10 and tick‐borne encephalitis.11 Also, markers of tuberculosis (Purified Protein Derivative) 12 and of rabies (animal bites) were included, in the latter case taking the average between two results with a 10‐fold difference.13,14 Data on malaria needed to be revised,15 and new evidence of a more than 10‐fold reduced incidence rate of hepatitis A recently necessitated in a major correction.16 Data on typhoid have very recently been confirmed by various groups in Europe and North America,17 with South Asia remaining the major risk destination. Throughout, travelers’ diarrhea remained the most frequent infectious health risk, with incidence rates exceeding 60% already in a 2‐week period at some destinations in all these surveys 18 (Figure 1). The proportion of travelers’ diarrhea associated with enterotoxigenic Escherichia coli was about 15%.19 Incidence rate per month of health problems during a stay in developing countries—2008. This scale was originally developed under the impression that travelers, also the less initiated among the travel health professionals, had misconceptions about what was frequent and what was rare and thus set wrong priorities. Those using this synopsis, however, must be aware of shortcomings, eg, that the meningitis and poliomyelitis data are old. The log scale shows the worst‐case scenarios, eg, the incidence rate of malaria and most other infections differs according to the destination. Tourists have a differing risk compared to those visiting friends and relatives.14 Also, among tourists, the risk may vary, eg, when one considers trekkers and cruise ship passengers in South America. Fortunately, the recently published account generated from Geosentinel data—although unable to provide incidence estimates—now offers the much needed evidence by region visited and by travelers’ characteristics.20 Based on systematic PubMed search—selecting, ie, “travel” and the specific infections—we will continue to update that logarithmic scale each year. We will try to include additional infections of relevance, eg, Norovirus, chikungunya, dermatological infections (eg, larva migrans, leishmaniasis), and emerging diseases—hopefully, data will become available. However, travelers do not only face infectious health risks. Let us remember that accidents are the most frequent cause of death abroad in developing countries 21 and that rate has been added to the figure.22 R. S. has accepted fees for speaking, organizing and chairing education, consulting, and/or serving on advisory boards, also reimbursement for attending meetings and funds for research from Astral, Baxter, Berna Biotech/Crucell, GlaxoSmithKline, Novartis Vaccine, Optimer, Roche, Salix, Sanofi Pasteur MSD, and/or SBL Vaccine. The other authors state that they have no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Steffen et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: